Biotechnology & Medical Research
Aug 21 (Reuters) - Adalta Ltd :FY net loss attributable to members A$2.8 million versus loss of A$1.2 million.FY revenue from ordinary activities $2 million versus $746,948.
Aug 18 (Reuters) - Stonepine Capital Management LLC::Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc as of August 11, 2017 - SEC filing.
Aug 18 (Reuters) - Agile Therapeutics Inc ::Caxton Corp reports 5.3 percent passive stake in Agile Therapeutics Inc as on August 9, 2017 - SEC filing.
No related earnings announcements are currently scheduled within the next 7 days.